<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="d669ff68-ddcf-42f6-913c-d8f1aedbd9c4"><labelDrug name="Veletri"><Normalization><mmtx cui="C1174787" preferredWord="Veletri" semType="phsu, orch"/></Normalization></labelDrug><generic name="epoprostenol sodium"/><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1" text="Drug Label for drug brand Veletri, containing epoprostenol sodium." type="negative"><entity charOffset="26:33" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.0" text="veletri" type="Biomedical_Entity"><Normalization><mmtx cui="C1174787" phraseText="Drug Label for drug brand Veletri," preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.1" text="epoprostenol sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0354594" phraseText="epoprostenol sodium." preferredWord="Epoprostenol Sodium" semType="eico, phsu"/><RxNorm RxCui="8814"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Veletri," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.1"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.0"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.1.e.1"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.14" text="&lt;item&gt;Reconstitute only as directed, with Sterile Water for Injection or Sodium Chloride 0.9% Injection.(5.1)" type="negative"><entity charOffset="42:55" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.14.e.0" text="sterile water" type="Biomedical_Entity"><Normalization><mmtx cui="C0359299" phraseText="with Sterile Water" preferredWord="sterile water" semType="inch, phsu"/><RxNorm RxCui="107129"/></Normalization></entity><entity charOffset="73:103" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.14.e.1" text="sodium chloride 0.9 injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0980221" phraseText="Sodium Chloride 0.9% Injection." preferredWord="Sodium Chloride 0.154 MEQ/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="9853"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.14.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.14.e.1"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19" text="Reconstitute VELETRI only as directed using Sterile Water for Injection, USP, or Sodium Chloride 0.9% Injection, USP. " type="negative"><entity charOffset="13:20" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.0" text="veletri" type="Biomedical_Entity"><Normalization><mmtx cui="C1174787" phraseText="VELETRI only" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><entity charOffset="81:111" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.1" text="sodium chloride 0.9 injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0980221" phraseText="Sodium Chloride 0.9% Injection," preferredWord="Sodium Chloride 0.154 MEQ/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="44:71" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.2" text="sterile water for injection" type="Biomedical_Entity"><Normalization><mmtx cui="C1163679" phraseText="Sterile Water for Injection," preferredWord="Water 1000 MG/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="107129"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.1"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.2"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.19.e.1"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.24" text="VELETRI is a potent pulmonary and systemic vasodilator. " type="negative"><entity charOffset="43:54" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.24.e.0" text="vasodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="systemic vasodilator." preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.24.e.1" text="veletri" type="Biomedical_Entity"><Normalization><mmtx cui="C1174787" phraseText="VELETRI" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.24.e.1" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.24.e.0"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.30" text="During chronic use, deliver VELETRI continuously on an ambulatory basis through a permanent indwelling central venous catheter. " type="negative"><entity charOffset="28:35" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.30.e.0" text="veletri" type="Biomedical_Entity"><Normalization><mmtx cui="C1174787" phraseText="VELETRI continuously on an ambulatory basis" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><entity charOffset="66:71" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.30.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="VELETRI continuously on an ambulatory basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.30.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.30.e.1"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.31" text="Unless contraindicated, administer anticoagulant therapy to patients receiving VELETRI to reduce the risk of pulmonary thromboembolism or systemic embolism through a patent foramen ovale. " type="negative"><entity charOffset="35:48" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.31.e.0" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536711" phraseText="anticoagulant therapy to patients" preferredWord="Anti-coagulant [EPC]" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="79:86" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.31.e.1" text="veletri" type="Biomedical_Entity"><Normalization><mmtx cui="C1174787" phraseText="VELETRI to" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.31.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.31.e.1"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.33" text="Because epoprostenol is metabolized rapidly, even brief interruptions in the delivery of VELETRI may result in symptoms associated with rebound pulmonary hypertension including dyspnea, dizziness, and asthenia. " type="negative"><entity charOffset="8:20" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.33.e.0" text="epoprostenol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033567" phraseText="epoprostenol" preferredWord="Epoprostenol" semType="eico, bacs, phsu"/><RxNorm RxCui="8814"/></Normalization></entity><entity charOffset="89:96" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.33.e.1" text="veletri" type="Biomedical_Entity"><Normalization><mmtx cui="C1174787" phraseText="even brief interruptions in the delivery of VELETRI" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.33.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.33.e.1"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.36" text="Adjust dosage of VELETRI during chronic use at the first sign of recurrence or worsening of symptoms attributable to pulmonary hypertension or the occurrence of adverse events associated with epoprostenol see Dosage and Administration (2). " type="negative"><entity charOffset="17:24" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.36.e.0" text="veletri" type="Biomedical_Entity"><Normalization><mmtx cui="C1174787" phraseText="dosage of VELETRI" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><entity charOffset="192:204" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.36.e.1" text="epoprostenol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033567" phraseText="associated with epoprostenol" preferredWord="Epoprostenol" semType="eico, bacs, phsu"/><RxNorm RxCui="8814"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.36.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.36.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45" lineNumber="60" text="Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. " type="regular"><entity charOffset="0:39" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.0" text="Additional reductions in blood pressure" type="Specific_Interaction"/><entity charOffset="55:62" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.2" text="VELETRI" type="Drug"><Normalization><mmtx cui="C1174787" phraseText="VELETRI" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><entity charOffset="84:93" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="administered with diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="95:118" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.4" text="antihypertensive agents" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="antihypertensive agents," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="129:141" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.5" text="vasodilators" type="Drug_Class"><Normalization><mmtx cui="C0042402" phraseText="other vasodilators." preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><drugInteraction id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.ddi.1"><interaction trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.5" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.3" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.4" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.3" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.5"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.4" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.5"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.3" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.45.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46" lineNumber="60" text="When other antiplatelet agents or anticoagulants are used concomitantly, there is the potential for VELETRI to increase the risk of bleeding. " type="regular"><entity charOffset="100:107" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.0" text="VELETRI" type="Drug"><Normalization><mmtx cui="C1174787" phraseText="the potential for VELETRI to" preferredWord="Veletri" semType="phsu, orch"/><RxNorm RxCui="1009213"/></Normalization></entity><entity charOffset="11:30" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.1" text="antiplatelet agents" type="Drug_Class"><Normalization><mmtx cui="C0085826" phraseText="other antiplatelet agents" preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="34:48" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.2" text="anticoagulants" type="Drug_Class"><Normalization><mmtx cui="C0003280" phraseText="anticoagulants" preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="132:140" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.3" text="bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.ddi.1"><interaction trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.1" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.0" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.0" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.46.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.47" text="However, patients receiving infusions of epoprostenol in clinical trials were maintained on anticoagulants without evidence of increased bleeding. " type="negative"><entity charOffset="92:106" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.47.e.0" text="anticoagulants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="maintained on anticoagulants" preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="41:53" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.47.e.1" text="epoprostenol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033567" phraseText="infusions of epoprostenol" preferredWord="Epoprostenol" semType="eico, bacs, phsu"/><RxNorm RxCui="8814"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.47.e.1" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.47.e.0"/></sentence><sentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48" text="In clinical trials, epoprostenol was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen." type="negative"><entity charOffset="56:65" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="88:100" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.1" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="oral vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="67:81" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.2" text="anticoagulants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="anticoagulants," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="47:54" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.3" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="used with digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="20:32" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.4" text="epoprostenol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033567" phraseText="epoprostenol" preferredWord="Epoprostenol" semType="eico, bacs, phsu"/><RxNorm RxCui="8814"/></Normalization></entity><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.1"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.2"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.3" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.0"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.4" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.0"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.1"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.3" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.1"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.4" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.1"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.3" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.2"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.4" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.2"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.4" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.48.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49" lineNumber="61" text="In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with epoprostenol was initiated, apparent oral clearance values for furosemide (n 23) and digoxin (n 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87. " type="regular"><entity charOffset="162:183|230:239" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.0" text="oral clearance values decreased" type="Increase_Interaction"/><entity charOffset="47:71" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.2" text="congestive heart failure" type="SPAN"><Normalization><mmtx cui="C0018802" phraseText="with congestive heart failure receiving furosemide" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="188:198" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.3" text="furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="apparent oral clearance values for furosemide" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="210:217" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.4" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="125:137" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.5" text="epoprostenol" type="Drug"><Normalization><mmtx cui="C0033567" phraseText="with epoprostenol" preferredWord="Epoprostenol" semType="eico, bacs, phsu"/><RxNorm RxCui="8814"/></Normalization></entity><drugInteraction id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.ddi.1"><interaction trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.0"><relations><relation type="hasObject"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.2" ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.5" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.3" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.0" type="Increase_Interaction"/><pair context="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.2" ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.5" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.4" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.49.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51" lineNumber="61" text="However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with epoprostenol, which may be clinically significant in patients prone to digoxin toxicity." type="regular"><entity charOffset="38:51|60:74" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.0" text="elevations of concentrations" type="Increase_Interaction"/><entity charOffset="52:59" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="elevations of digoxin concentrations" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="108:120" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.3" text="epoprostenol" type="Drug"><Normalization><mmtx cui="C0033567" phraseText="with epoprostenol," preferredWord="Epoprostenol" semType="eico, bacs, phsu"/><RxNorm RxCui="8814"/></Normalization></entity><drugInteraction id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.ddi.1"><interaction trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.2" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.3" trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52" lineNumber="64" text="&lt;item&gt;Diuretics, antihypertensive agents, or other vasodilators: reduction in blood pressure (7)" type="irregular"><entity charOffset="6:15" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.0" text="Diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="&gt;Diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="17:40" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.1" text="antihypertensive agents" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="antihypertensive agents," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="51:63" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.2" text="vasodilators" type="Drug_Class"><Normalization><mmtx cui="C0042402" phraseText="other vasodilators" preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="65:92" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.3" text="reduction in blood pressure" type="Specific_Interaction"/><drugInteraction id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.ddi.1"><interaction trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51" text="However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with epoprostenol, which may be clinically significant in patients prone to digoxin toxicity."><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.3"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.2"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.1" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.2"/><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53" lineNumber="66" text="&lt;item&gt;Antiplatelet agents or anticoagulants: increase the risk of bleeding (7)" type="irregular"><entity charOffset="6:25" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.0" text="Antiplatelet agents" type="Drug_Class"><Normalization><mmtx cui="C0085826" phraseText="&gt;Antiplatelet agents" preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="29:43" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.1" text="anticoagulants" type="Drug_Class"><Normalization><mmtx cui="C0003280" phraseText="anticoagulants" preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="66:74" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.2" text="bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.ddi.1"><interaction trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51" text="However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with epoprostenol, which may be clinically significant in patients prone to digoxin toxicity."><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.3"/></ellipsisSentence><middleSentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52" text="&lt;item&gt;Diuretics, antihypertensive agents, or other vasodilators: reduction in blood pressure (7)"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.0" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.54" lineNumber="68" text="&lt;item&gt;Patients on digoxin: elevations of digoxin concentrations clinically significant in patients prone to digoxin toxicity (7)" type="irregular"><entity charOffset="27:40|49:63" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.54.e.0" text="elevations of concentrations" type="Increase_Interaction"/><entity charOffset="41:48" id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.54.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="elevations of digoxin concentrations" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.54.ddi.1"><interaction trigger="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.54.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51" text="However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with epoprostenol, which may be clinically significant in patients prone to digoxin toxicity."><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.51.e.3"/></ellipsisSentence><middleSentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.52" text="&lt;item&gt;Diuretics, antihypertensive agents, or other vasodilators: reduction in blood pressure (7)"/><middleSentence id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.53" text="&lt;item&gt;Antiplatelet agents or anticoagulants: increase the risk of bleeding (7)"/></relation><relation type="hasObject"><entity id="Dailymed.d669ff68-ddcf-42f6-913c-d8f1aedbd9c4.s.54.e.2"/></relation></relations></interaction></drugInteraction></sentence><positiveExamples number="13"/><negativeExamples number="30"/></document>